Drug intelligence / Profile preview

Probiotical

Development stage
Unknown
Lead developer
Probiotical
Modality
Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
Administration
Oral
01

Overview

Probiotical is a brand name for a range of probiotic products developed and manufactured by the company Probiotical. These products contain live microorganisms, typically specific strains of beneficial bacteria such as Lactobacillus and Bifidobacterium species, designed to confer health benefits when administered in adequate amounts. The primary mechanism of action involves modulation and restoration of the gut microbiota, inhibition of pathogenic microorganisms, production of bioactive metabolites (such as short-chain fatty acids), reinforcement of gut barrier function, vitamin synthesis, bile salt metabolism, enzymatic activity enhancement, toxin neutralization, and immunomodulation. Clinical uses include prevention or treatment of antibiotic-associated diarrhea, acute infectious diarrhea, irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), bacterial vaginosis, pediatric candidemia/candiduria, necrotizing enterocolitis in neonates, upper respiratory tract infections (URTIs), blood pressure regulation support in some populations and ventilator-associated pneumonia. Evidence for efficacy varies by strain and indication; proven benefits are strongest for certain types/strains in acute diarrhea and antibiotic-associated diarrhea[1][4][5][6][8].

Brand names
Probiotical

Beyond the preview

Go deeper on Probiotical.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Probiotical.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call